01
ABM
From 100 accounts to 1,500 verified stakeholders
Account lists that missed subsidiaries and buying committees, rebuilt around how these institutions actually operate.
CCM Software Vendor
Read →
02
Market entry
Building qualified market entry datasets across regulated financial markets
Two heavily regulated markets with no reliable public data on licensed institutions, mapped from regulatory sources.
Swiss Fintech Vendor, UAE and Caribbean
Read →
03
High volume
Building a high-volume outbound system from product-level signals
Targeting "ecommerce companies" was too broad. Segmenting on product type instead of company type kept volume and relevance together.
North American Mid-Sized Software Vendor
Read →
04
Long-term
Building and expanding a partner-driven outbound system
Five broker personas and two motions running in parallel: new partner acquisition alongside expansion inside existing firms.
US-Based Valuation Report Provider
Read →
05
High volume
Targeting owner-led businesses in timing-driven markets
A market where low engagement is structural rather than a failure. The system was built for seller readiness, not for a response-rate benchmark.
Business Broker, Manufacturing and Home Services
Read →
06
Strategy + execution
Defining and validating an ICP before scaling outbound
The outbound buyer turned out to be structurally different from the inbound buyer. Finding that first kept the program small and working.
Mobile Food Solutions Manufacturer
Read →
07
International expansion
Launching outbound across multiple countries with localized execution
Bilingual execution across several LATAM markets, with messaging built per region rather than translated from English templates.
Swiss Software Vendor, LATAM
Read →
08
Niche targeting
Building targeting systems for hard-to-reach industrial markets
An ICP that does not exist in Apollo or ZoomInfo, built instead from niche industrial directories and mapped across two stakeholder groups.
Industrial Labels Manufacturer
Read →
09
ABM
Identifying decision-makers across 400 pharma accounts using signal-based targeting
The same role carried 20 to 40+ different titles. Matching on titles would have missed most of the buying population, so we stopped matching on titles.
Pharmaceutical Research Services Company
Read →